Remimazolam for sedation: A protocol for a systematic review with meta-analysis, trial sequential analysis, and GRADE...

Area of Science:

• Anesthesiology and Pharmacology
• Clinical Trial Methodology

Background:

• Procedural sedation is crucial for patient comfort during medical procedures.
• Midazolam and propofol are common sedatives but have risks like respiratory depression and hypotension.
• Remimazolam presents a potential alternative with a favorable pharmacokinetic and pharmacodynamic profile.

Purpose of the Study:

• To systematically review the clinical efficacy and safety of remimazolam for procedural sedation.
• To compare remimazolam against placebo or other sedatives in adult patients.
• To assess remimazolam's impact on sedation success, respiratory, and hemodynamic complications.

Main Methods:

• Systematic review following PRISMA guidelines.
• Inclusion of all randomized controlled trials.
• Data extraction and risk of bias assessment by independent reviewers.
• Meta-analysis using Rstudio and GRADE for evidence certainty.

Main Results:

• Primary outcomes include sedation success rate, respiratory complications, and hemodynamic complications.
• Secondary outcomes encompass quality of recovery and serious adverse events.
• The review will quantify the benefits and harms of remimazolam.

Conclusions:

• This systematic review provides an up-to-date assessment of remimazolam's clinical effects in procedural sedation.
• Results are expected to inform clinical decision-making regarding remimazolam use.
• The findings will guide clinicians in optimizing procedural sedation strategies.